QT Imaging is shifting from survival mode to growth, leveraging minimum order deals and a recent uplisting to NASDAQ. Their QT Scan technology offers advantages over traditional mammograms, with ongoing studies potentially proving its superiority. The company projects $39 million in revenue and near-EBITDA breakeven by 2026, driven by strong demand in the US and Middle East, although geopolitical issues have delayed deliveries in the Gulf. Future growth depends on distributor renewals, insurance reimbursement, and expanding international deals, with potential political support as an additional catalyst.
Bitcoin is strengthening its dominance in the cryptocurrency market as capital concentrates on major assets, while altcoins struggle with high selling pressure and reduced trading volumes. The traditional cycle where gains rotate from Bitcoin to altc...
Analyst David Zanoni expects Bitcoin to reach a bottom near $38,000 around September 2026, based on historical four-year price cycles. He highlights IBIT as an accessible trading option during Bitcoin's bull and bear markets, though current technical...
PI Network's native token, PI, gained over 9% this week following a successful upgrade of most mainnet node operators to Protocol v25. This upgrade is seen as a bullish catalyst, pushing PI's price toward the key resistance level of $0.14, which has ...
US spot Bitcoin ETFs experienced a record $6 billion outflow over the past 30 days, driven by a 17% drop in Bitcoin's price and a 13-day consecutive redemption streak. The largest outflows came from BlackRock's IBIT and Fidelity's FBTC funds. This se...
US-listed spot Bitcoin ETFs experienced a record $6.4 billion outflow over 30 days as Bitcoin's price fell 17% to the mid-$60,000 range. This reflects declining institutional confidence and a broader risk-off sentiment during the ongoing crypto winte...
